Mexia Principal Healthcare Limited Partnership
Mexia Principal Healthcare Limited Partnership was paid $2.19M by Medicaid between Nov 2020 and Nov 2024, across 34 billing codes. Its largest line is 99283, emergency room visit (moderate) — 47% of everything it billed.
MEXIA, TX 76667
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 82 | $8K | |
| 2021 | 4,902 | $304K | |
| 2022 | 6,969 | $962K | |
| 2023 | 6,043 | $759K | |
| 2024incomplete | 1,421 | $154K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 47% | 3,967 | 3,813 | $1.02M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 36% | 1,495 | 1,429 | $791K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.2% | 498 | 484 | $91K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.2% | 1,077 | 1,018 | $69K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.9% | 1,772 | 1,714 | $43K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.6% | 124 | 119 | $36K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.4% | 1,520 | 1,466 | $30K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 200 | 190 | $18K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 156 | 152 | $16K |
| 87070 | <1% | 834 | 807 | $15K | |
| 87081 | <1% | 897 | 870 | $12K | |
| 87430 | <1% | 194 | 191 | $9K |
22 more codes
| 80053 | Comprehensive metabolic panel | <1% | 1,638 | $9K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 115 | $8K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,694 | $6K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 65 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 14 | $1K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 98 | $920.98 |
| 99285 | Emergency room visit (most serious) | <1% | 13 | $909.38 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 182 | $620.02 |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,801 | $609.51 |
| 87420 | <1% | 13 | $452.40 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 12 | $443.62 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 366 | $382.97 |
| 80061 | Lipid panel | <1% | 258 | $257.04 |
| 81001 | <1% | 42 | $218.69 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 88 | $150.07 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 14 | $146.93 |
| 71045 | Radiologic examination, chest; single view | <1% | 28 | $79.76 |
| 84484 | <1% | 50 | $61.70 | |
| 81003 | <1% | 92 | $32.96 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 26 | $14.19 |
| A9270 | Non-covered item or service | 0% | 44 | $0.00 |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 0% | 30 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Logan General Hospital LLC | Logan, WV | $43.43M |
| Phc-Cleveland LLC | Cleveland, MS | $23.43M |
| Hartsville, LLC | Hartsville, SC | $18.42M |
| Logan Memorial Hospital LLC | Russellville, KY | $14.29M |
| Southwestern Medical Center, LLC | Lawton, OK | $9.40M |
| Palestine Principal Healthcare Limited Partnership | Palestine, TX | $6.80M |
| Watertown Medical Center LLC | Watertown, WI | $6.31M |
| Amg - Livingston, LLC | Livingston, TN | $5.52M |
| Logan General Hospital LLC | Logan, WV | $4.91M |
| ST. Joseph Hospital LLC | Lewiston, ID | $4.67M |
| Riverton Memorial Hospital LLC | Riverton, WY | $4.65M |
| Livingston Regional Hospital LLC | Livingston, TN | $4.33M |
| Hartsville Medical Group LLC | Hartsville, SC | $4.16M |
| Palestine Principal Healthcare Limited Partnership | Palestine, TX | $1.27M |
| Texas Specialty Physicians | Palestine, TX | $1.26M |
| ST Joseph Hospital LLC | Lewiston, ID | $1.10M |
| Watertown Physician Practices LLC | Watertown, WI | $244K |
| Watertown Physician Practices LLC | Watertown, WI | $175K |
| Amg-Livingston LLC | Livingston, TN | $165K |
| Watertown Physician Practices LLC | Watertown, WI | $149K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.